Acute Liver Failure: Pathophysiologic Basis, and The Current and Emerging Therapies - European Medical Journal

Acute Liver Failure: Pathophysiologic Basis, and The Current and Emerging Therapies

Download PDF
Graziella Privitera, Banwari Agarwal, *Rajiv Jalan

No potential conflict of interest.

EMJ Hepatol. ;1[1]:99-107. DOI/10.33590/emjhepatol/10313515.
Acute liver failure, intracranial hypertension, multi-organ failure, liver transplantation, N-acetylcysteine, acetaminophen.

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.


Acute liver failure (ALF) is a devastating condition that occurs in patients who previously had a normal liver. Although the outcome of patients with ALF has improved, without liver transplantation (LT) mortality rates remain in the range of 35-50% in different geographical areas and therefore, its treatment remains an unmet need. In the Western world toxic liver injury from acetaminophen remains one of the common causes but, in the East, hepatitis of unknown aetiology remains the most common cause. Treatment options are limited to meticulous attention to multi-organ support, use of N-acetyl cysteine, judicious use of antibiotics, and timely LT. This review describes the state-of-the-art techniques in the issues related to prognosis, outcome, and treatment of this devastating syndrome.

Please view the full content in the pdf above.

Please rate the quality of this content

As you found this content interesting...

Follow us on social media!

We are sorry that this content was not interesting for you!

Let us improve this content!

Tell us how we can improve this content?

Keep your finger on the pulse

Join Now

Elevating the Quality of Healthcare Globally